PKC alpha Antikörper (pTyr658)
Kurzübersicht für PKC alpha Antikörper (pTyr658) (ABIN5874075)
Target
Alle PKC alpha (PKCa) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- pTyr658
- 
                                            Aufreinigung
- Affinity Chromatography
- 
                                            Immunogen
- Peptide sequence around phosphorylation site of tyrosine 658 (F-S-Y (p)-V-N) derived from Human PKC .
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, containing 150 mM NaCl, 0.02 % sodium azide and 50 % Glycerol.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
 
- 
                                            
- 
    - PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))
- 
                                            Andere Bezeichnung
- PRKCA
- 
                                            UniProt
- P17252
- 
                                            Pathways
- WNT Signalweg, T-Zell Rezeptor Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
 Target
- 
                    
 
                                     
                                     
                                    